GeVIR Banner
Genes Fold Enrichment Color Codes
  • Gene Name, Canonical Transcript - gene identifiers from gnomAD database (Build 37)
  • GeVIR % - gene rank measured in percentiles based on Gene Variation Intolerance Ranking (GeVIR) (low values indicate more variation intolerant genes, which is also true for "LOEUF %" and "VIRLoF %"). GeVIR is a method which we developed and applied on a list of 19,361 genes to sort them based on number, length and evolutionary conservation of regions without functional variants (i.e. between two missense, loss-of-function, insertion or delition variants) in gnomAD database (version 2.0.1). Only canonical transcripts were analysed.
  • LOEUF % - gene rank measured in percentiles based gnomAD loss-of-function observed/expected upper bound fraction (LOEUF) (see Figure 1). For more information about this metric, please read "Constraint" section of MacArthur Lab blog post. If you use this metric please cite gnomAD flagship paper and use most up-to-date values from gnomAD website.

    LoF observed/expected (o/e) upper Confidence Interval (CI)

    Figure 1. Screenshot of ELN gene constraint metrics from gnomAD browser

  • VIRLoF % - gene rank measured in percentiles based on both GeVIR and gnomAD LOEUF (shows the best overall performance, see Figure 2). If you use this metric please cite both GeVIR and gnomAD flagship paper.
  • GeVIR AD, LOEUF AD, VIRLoF AD, GeVIR AR, LOEUF AR, VIRLoF AR - to help users interpret gene ranks, we calculated fold enrichment of Autosomal Dominant (AD) and Autosomal Recessive (AR) genes with known molecular basis of disorder in OMIM in a range of +-5% of gene X (see Figure 2). Statistical significant fold enrichements (Fisher Exact Test p-value < 1e-5) are shown in bold in the table. For example CDK19 gene's GeVIR % is 2.37, so examined range is from 0 (2.37-5, rounded to minimal percentile) to 7.37% (2.37+5). Genes in this range are ~4 times more often (4.05 fold enrichement) associated with AD diseases and ~4 times less often (0.25 fold enrichement) associated with AR diseases. Both enrichment of AD genes and deficiency of AR genes is statistical significant. Thus GeVIR metric adds supportive evidence that CDK19 is more likely to be associated with AD than AR disease.

    Gene Percentiles AD AR Fold Enrichment

    Figure 2. Fold Enrichment of known Autosomal Dominant (AD) and Autosomal Recessive (AR) genes of each gene in the ranked lists (GeVIR, LOEUF, VIRLoF. AD genes are enriched among top ranked genes (lowest percentiles), whereas AR genes are enriched among middle ranked genes (approximetly 35-65 percentiles). Combined metric (VIRLoF, purple) shows the best perfornance, i.e. high ranked genes are more often associated with AD than AR diseases, low ranked genes are less often associated with both AD and AR diseases.
Gene Name Canonical Transcript GeVIR % LOEUF % VIRLoF % GeVIR AD LOEUF AD VIRLoF AD GeVIR AR LOEUF AR VIRLoF AR
OR5T1 ENST00000313033 95.93 99.96 99.48 0.11 0.18 0.11 0.11 0.09 0.05
FAM47B ENST00000329357 96.05 99.77 99.48 0.11 0.17 0.11 0.11 0.11 0.05
PYDC1 ENST00000302964 97.57 98.15 99.47 0.10 0.20 0.11 0.11 0.16 0.05
MAGEB1 ENST00000378981 98.07 97.72 99.47 0.11 0.21 0.11 0.11 0.17 0.05
PRB2 ENST00000389362 98.52 97.34 99.46 0.10 0.23 0.11 0.11 0.19 0.05
ZNF835 ENST00000537055 97.03 98.52 99.46 0.10 0.21 0.11 0.11 0.15 0.05
OR13C5 ENST00000374779 96.76 98.86 99.45 0.11 0.16 0.11 0.11 0.14 0.05
RP11-3B7.1 ENST00000440528 97.98 97.75 99.45 0.11 0.21 0.11 0.11 0.17 0.05
IL3 ENST00000296870 99.82 95.99 99.44 0.12 0.22 0.11 0.13 0.20 0.05
DIRC1 ENST00000308100 96.69 99.86 99.44 0.11 0.17 0.11 0.11 0.11 0.05
ZFP42 ENST00000326866 96.32 99.33 99.43 0.12 0.16 0.11 0.11 0.12 0.05
BLID ENST00000560104 96.18 99.49 99.43 0.11 0.16 0.11 0.11 0.13 0.05
MRGPRX3 ENST00000396275 95.80 99.89 99.42 0.11 0.17 0.11 0.11 0.11 0.05
PRR23B ENST00000329447 96.91 98.57 99.42 0.09 0.20 0.11 0.11 0.15 0.05
C19orf48 ENST00000598463 96.58 98.96 99.41 0.11 0.17 0.11 0.11 0.15 0.05
VN1R2 ENST00000341702 96.21 99.37 99.41 0.12 0.16 0.11 0.11 0.12 0.05
TMEM14E ENST00000408960 96.15 99.43 99.40 0.11 0.16 0.11 0.11 0.12 0.05
MAGEB6 ENST00000379034 97.51 98.03 99.40 0.10 0.20 0.11 0.11 0.16 0.04
PRB4 ENST00000279575 98.23 97.43 99.39 0.09 0.22 0.11 0.11 0.19 0.04
SCGB1A1 ENST00000278282 99.51 96.14 99.39 0.12 0.21 0.11 0.13 0.20 0.04
OR2T3 ENST00000359594 97.29 99.76 99.38 0.10 0.17 0.11 0.11 0.11 0.04
MUC7 ENST00000413702 99.86 95.76 99.38 0.12 0.23 0.11 0.13 0.20 0.04
KRTAP19-6 ENST00000334046 96.04 99.34 99.37 0.11 0.16 0.11 0.11 0.12 0.04
IFNA17 ENST00000413767 96.77 98.50 99.36 0.11 0.21 0.11 0.11 0.15 0.04
MRPL36 ENST00000508987 96.48 98.82 99.36 0.10 0.16 0.11 0.11 0.14 0.04

Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.